Cargando…
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules
Antiviral agents are needed for the treatment of SARS-CoV-2 infections and to control other coronavirus outbreaks that may occur in the future. Here we report the identification and characterization of RNA-binding compounds that inhibit SARS-CoV-2 replication. The compounds were detected by screenin...
Autores principales: | Simba-Lahuasi, Alvaro, Cantero-Camacho, Ángel, Rosales, Romel, McGovern, Briana Lynn, Rodríguez, M. Luis, Marchán, Vicente, White, Kris M., García-Sastre, Adolfo, Gallego, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784969/ https://www.ncbi.nlm.nih.gov/pubmed/36558898 http://dx.doi.org/10.3390/ph15121448 |
Ejemplares similares
-
Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture
por: Bafna, Khushboo, et al.
Publicado: (2021) -
The conserved 3′X terminal domain of hepatitis C virus genomic RNA forms a two-stem structure that promotes viral RNA dimerization
por: Cantero-Camacho, Ángel, et al.
Publicado: (2015) -
When Actions Speak Louder Than Words: Extending the Reach of Qualitative Data Collecting
por: McGovern, Justine
Publicado: (2016) -
An unexpected RNA distal interaction mode found in an essential region of the hepatitis C virus genome
por: Cantero-Camacho, Ángel, et al.
Publicado: (2018) -
Structure function characterization of SARS CoV2 proteases for COVID19 antiviral development
por: Greene-Cramer, Rebecca, et al.
Publicado: (2022)